CRBP vs IQV · $102.3M cap vs P/E 23, rev $16.31B
Corbus Pharmaceuticals Holding (CRBP) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
CRBP does not have a complete income-statement cache yet.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
CRBP currently screens at market cap $102.3M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the CRBP and IQV stock pages for the full models.
Not investment advice.